Author:
Joginapally Venkateshwara Rao
Publisher
Akshantala Enterprises Private Limited
Reference12 articles.
1. [1] Aldrich JV, McLaughlin JP. Opioid peptides: potential for drug development. Drug Discov Today Technol 2012;9(1):e23-e31.
2. [2] National Research Council (US) Committee on Recognition and Alleviation of Pain in Laboratory Animals. Recognition and alleviation of pain in laboratory animals. (Mechanisms of pain). Washington (DC): National Academies Press (US) 2009.
3. [3] Peckham AM, De La Cruz A, Dufresne RL. Kappa opioid receptor antagonism: are opioids the answer for treatment resistant depression? Ment Health Clin 2018;8(4):175-83.
4. [4] Sehgal N, Smith HS, Manchikanti L. Peripherally acting opioids and clinical implications for pain control. Pain Physician 2011;14(3):249-58.
5. Design, synthesis and opioid activity of arodyn analogs cyclized by ring-closing metathesis involving Tyr (allyl);Fang;Bioorg Med Chem,2018